<DOC>
	<DOCNO>NCT00034697</DOCNO>
	<brief_summary>Brain metastasis solid tumor diagnose 300,000 patient annually . Nonsmall cell lung cancer account majority CNS mets . Treatment whole brain radiation steroid improve neurologic symptom 50 % patient although survival short . This study test safety efficacy temozolomide combination radiation therapy treatment patient brain mets form nonsmall cell lung cancer .</brief_summary>
	<brief_title>Study Temozolomide Treatment Brain Metastasis From Non-small-cell Lung Cancer ( Study P02143 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histologic confirmation nonsmallcell lung cancer Stable systemic disease Maximum one prior chemotherapy regimen metastatic systemic disease Radiotherapy local control palliative bony lesion allow Karnofsky great equal 70 % Adequate hematologic , renal liver function Patients eligible surgery brain Any previous chemotherapy brain metastasis Chemotherapy within 4 week previous temozolomide Prior radiotherapy brain Radiation therapy great 50 % bone marrow Insufficient recovery previous therapy Active nonmalignant systemic disease Inability take oral medication Pregnant nursing woman Non use adequate contraceptive technique , negative urine pregnancy test require Known AIDS relate illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Brain mets</keyword>
	<keyword>non-small cell lung cancer</keyword>
</DOC>